Clinical

Dataset Information

FOLFIRI Alone Versus FOLFIRI Plus Bevacizumab Versus FOLFIRI Plus E7820 as Second-Line Therapy in Patients With Locally Advanced or Metastatic Colorectal Cancer


ABSTRACT: The purpose of the Phase Ib portion is to find out the highest dose of study drug that can safely be given when tested in a small group of subjects. The purpose of the Phase II portion is to find out how safe the study drug is when taken at the highest dose in a larger group of subjects.

DISEASE(S): Colorectal Cancer,Colorectal Neoplasms

PROVIDER: 2089917 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR